144 related articles for article (PubMed ID: 2283256)
21. Magnetic resonance imaging contrast agents.
Runge VM
Curr Opin Radiol; 1992 Feb; 4(1):3-12. PubMed ID: 1739599
[TBL] [Abstract][Full Text] [Related]
22. Use of MR imaging contrast agents in the brain.
Bradley WG; Yuh WT; Bydder GM
J Magn Reson Imaging; 1993; 3(1):199-218. PubMed ID: 8428088
[No Abstract] [Full Text] [Related]
23. Gadolinium-DTPA: a new contrast agent.
Niendorf HP
Bristol Med Chir J; 1988 May; 103(2):34. PubMed ID: 3219630
[No Abstract] [Full Text] [Related]
24. Histologic abnormalities associated with gadolinium enhancement on MR in the initial hours of experimental cerebral infarction.
Mathews VP; Monsein LH; Pardo CA; Bryan RN
AJNR Am J Neuroradiol; 1994 Mar; 15(3):573-9. PubMed ID: 8197960
[TBL] [Abstract][Full Text] [Related]
25. In vivo quantification of the blood-brain barrier injury using magnetic resonance enhancement.
Hayakawa K; Yamashita K; Mitsumori M; Nakano Y
Invest Radiol; 1990 Sep; 25 Suppl 1():S80-1. PubMed ID: 2283266
[No Abstract] [Full Text] [Related]
26. Safety assessment of gadopentetate dimeglumine in U.S. clinical trials.
Goldstein HA; Kashanian FK; Blumetti RF; Holyoak WL; Hugo FP; Blumenfield DM
Radiology; 1990 Jan; 174(1):17-23. PubMed ID: 2403679
[TBL] [Abstract][Full Text] [Related]
27. Subchronic toxicity of the gadolinium chelates.
Runge VM; Kuehl TJ; Jackson CB; Estrada EA
Acad Radiol; 2005 May; 12 Suppl 1():S6-9. PubMed ID: 16106537
[No Abstract] [Full Text] [Related]
28. Effects of Gd-DTPA after osmotic BBB disruption in a rodent model: toxicity and MR findings.
Roman-Goldstein SM; Barnett PA; McCormick CI; Szumowski J; Shannon EM; Ramsey FL; Mass M; Neuwelt EA
J Comput Assist Tomogr; 1994; 18(5):731-6. PubMed ID: 8089321
[TBL] [Abstract][Full Text] [Related]
29. The effect of Gd-dimeglumine on subcutaneous tissues: a study with rats.
McAlister WH; McAlister VI; Kissane JM
AJNR Am J Neuroradiol; 1990; 11(2):325-7. PubMed ID: 2107714
[TBL] [Abstract][Full Text] [Related]
30. Gadolinium-enhanced MRI of pigmented villonodular synovitis of the knee.
Bessette PR; Cooley PA; Johnson RP; Czarnecki DJ
J Comput Assist Tomogr; 1992; 16(6):992-4. PubMed ID: 1430457
[No Abstract] [Full Text] [Related]
31. Gadopentetate dimeglumine as a marker of renal function. Magnetic resonance imaging to glomerular filtration rates.
Frank JA; Choyke PL; Austin HA; Girton ME; Weiss G
Invest Radiol; 1991 Nov; 26 Suppl 1():S134-6; discussion S137-8. PubMed ID: 1808110
[No Abstract] [Full Text] [Related]
32. Inflammatory joint disease: static and dynamic gadolinium-enhanced MR imaging.
Reiser MF; Naegele M
J Magn Reson Imaging; 1993; 3(1):307-10. PubMed ID: 8428098
[No Abstract] [Full Text] [Related]
33. Noninvasive measurement of renal hemodynamic functions using gadolinium-enhanced magnetic resonance imaging.
Katzberg RW; Dumoulin CL; Buonocore MA; Opsahl LR; Darrow RD; Morris TW
Invest Radiol; 1994 Jun; 29 Suppl 2():S123-6. PubMed ID: 7928206
[No Abstract] [Full Text] [Related]
34. Is it necessary to routinely use gadolinium in the MR imaging evaluation of soft-tissue tumors of the extremities?
Kransdorf MJ
AJR Am J Roentgenol; 1995 Dec; 165(6):1545. PubMed ID: 7484606
[No Abstract] [Full Text] [Related]
35. Gadopentetate dimeglumine-enhanced MR imaging of subdural hematoma in an abused infant.
Kleinman PK; Ragland RL
AJR Am J Roentgenol; 1996 Jun; 166(6):1456-8. PubMed ID: 8633463
[No Abstract] [Full Text] [Related]
36. In vitro interactions of gadolinium DOTA meglumine and gadolinium DTPA meglumine on hemostasis.
Corot C; Belleville J; Paul J; Baguet J; Amiel M; Eloy R
Invest Radiol; 1988 Sep; 23 Suppl 1():S261-3. PubMed ID: 3198358
[TBL] [Abstract][Full Text] [Related]
37. [Artificial contrasting during magnetic resonance tomography].
Sergeev PV; Panov OV; Egorova SV; Bolotova EN; Shimanovskii NL; Akhadov TA; Sviridov NK
Vestn Rentgenol Radiol; 1997; (1):45-52. PubMed ID: 9133071
[No Abstract] [Full Text] [Related]
38. [Anaphylactoid reaction caused by intravenous gadopentetate dimeglumine in magnetic resonance].
Campos A; Aznar L; Alamar R; Castelló JV
Med Clin (Barc); 1996 Feb; 106(5):197. PubMed ID: 8684023
[No Abstract] [Full Text] [Related]
39. Gadodiamide injection. First human experience with the nonionic magnetic resonance imaging enhancement agent.
Van Wagoner M; Worah D
Invest Radiol; 1993 Mar; 28 Suppl 1():S44-8. PubMed ID: 8486503
[TBL] [Abstract][Full Text] [Related]
40. Comparison of Gd-BOPTA with Gd-DTPA in MR imaging of rat liver.
Pavone P; Patrizio G; Buoni C; Tettamanti E; Passariello R; Musu C; Tirone P; Felder E
Radiology; 1990 Jul; 176(1):61-4. PubMed ID: 2353112
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
